medigraphic.com
ISSN 1684-1824 (Electronic)

2022, Number 3

<< Back Next >>

Rev Méd Electrón 2022; 44 (3)

Clinical characterization of chronic hypertensive pregnant women. Provincial Teaching Gynecobstetric Hospital José Ramón López Tabrane

Medina-Rodríguez D, Pérez-García L, González-Cristóbal K, Pintado-Chaviano J, Martínez-Oña OC, González-Rodríguez G

Language: Spanish
References: 20
Page: 560-572
PDF size: 1046.43 Kb.


ABSTRACT

Introduction: chronic arterial hypertension during pregnancy is associated with an increase in obstetric and perinatal complications.
Objective: to characterize chronic hypertensive pregnant women at Provincial Teaching Gynecobstetric Hospital José Ramón Lopez Tabrane.
Materials and methods: descriptive-prospective study carried out by reviewing the medical records, interviews and examination of pregnant women who were admitted to the Provincial teaching Gynecobstetric Hospital José Ramón López Tabrane, between September 2020 and September 2021, with a diagnosis of chronic arterial hypertension. Eight variables were identified and their prevalence was estimated using absolute and relative frequencies.
Results: 126 pregnant women were studied, 86 of whom were 35 years old or older, most classified as mild hypertensive. In 89 cases, some associated disease was present. 25.4 % presented normal weight gain. In 81 % of patients, cesarean section was used as a way to end the pregnancy. The main complications were: preterm delivery (27.1 %), preeclampsia (16.7 %), oligohydramnios (16.7 %) and intrauterine growth restriction (13.5 %). Four neonatal deaths occurred. Postpartum evolution was unsatisfactory in 24 cases.
Conclusions: the hypertensive pregnant woman was generally older than 35 years, with anemia as an associated entity. Chronic mild arterial hypertension prevailed, with excessive weight gain. The way of ending pregnancy of choice was cesarean section, which prevailed in full-term pregnancies. The main complications were pre-term deliveries and overadded preeclampsia, oligohydramnios and intrauterine growth restriction.


REFERENCES

  1. Say L, Chou D, Gemmill A, et al . Global causes of maternal death: a WHO systematic analysis. Lanc Glob Health [Internet]. 2014 [citado 10/03/2022];2(6):e323-33. Disponible en: Disponible en: https://www.sciencedirect.com/science/article/pii/S2214109X1470227X 1.

  2. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J [Internet]. 2018 [citado 10/03/2022];39(34):165-241. Disponible en: Disponible en: https://academic.oup.com/eurheartj/article/39/34/3165/5078465 2.

  3. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin number 202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1. Citado en PubMed; PMID: 30575675.

  4. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin number 203: Chronic hypertension in Pregnancy. Obstet Gynecol. 2019;133(1):e26-e50. Citado en PubMed; PMID: 30575676.

  5. Butalia S, Audibert F, Côté AM, et al. Hypertension Canada's 2018 Guidelines for the Management of Hypertension in Pregnancy. Canad J Cardiol. 2018;34(5):526-31. Citado en PubMed; PMID: 29731014.

  6. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J [Internet]. 2018 [citado 11/03/2022];39(33):3021-3104. Disponible en: Disponible en: https://academic.oup.com/eurheartj/article/39/33/3021/5079119 6.

  7. Toirac A, Pascual A, Blanco G, et al. Enfermedades crónicas no transmisibles. Caracterización comparativa para gestantes portadoras y su descendencia. Medisan [Internet]. 2013 [citado 12/03/2022];17(12):9094-9109. Disponible en: Disponible en: https://medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=46959 7.

  8. Velásquez AJ. Hipertensión postparto. Rev Colomb Obstet Ginecol [Internet]. 2005 [citado 12/03/2022];56(2):141-6. Disponible en: Disponible en: http://www.scielo.org.co/scielo.php?pid=S0034-74342005000200005&script=sci_abstract&tlng=es 8.

  9. Rodríguez A, Rodríguez R. Insuficiencia renal crónica en pacientes con diabetes mellitus de tipo 2 en un área de salud. Medisan [Internet]. 2009 [citado 12/03/2022];13(6). Disponible en: Disponible en: https://www.redalyc.org/articulo.oa?id=368448456008 9.

  10. Howell KR, Powell TL. Effects of maternal obesity on placental function and fetal development. Reproduction. 2017;153(3):97-108. Citado en PubMed; PMID: 27864335.

  11. Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences. BMJ [Internet]. 2017 [citado 12/03/2022];365(1). Disponible en: Disponible en: https://www.bmj.com/content/356/bmj.j1 11.

  12. Moreno Z, Sánchez S, Piña F, et al. Obesidad pregestacional como factor de riesgo asociado a preeclampsia. An Fac Med [Internet]. 2003 [citado 12/03/2022];64(2):101-6. Disponible en: Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832003000200004&Ing=es 12.

  13. Altanuga Palacio M, Lugones Botell M. Incidencia de algunos factores de riesgos en la preeclampsia con signos de gravedad. Rev Cubana Obst Ginecol [Internet]. 2010 [citado 12/03/2022];36(3):352-9. Disponible en: Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/lil-584640 13.

  14. Lacunza R, Pacheco J. Preeclampsia de inicio temprano y tardío: una antigua enfermedad, nuevas ideas. Rev Peru Ginecol Obstet [Internet]. 2010 [citado 12/03/2022];60(4):351-62. Disponible en: Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2304-51322014000400011&Ing=es 14.

  15. Pacheco R. Gestación en la mujer obesa, consideraciones especiales. An Fac Med [Internet]. 2017 [citado 12/03/2022];78(2):207-14. Disponible en: Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832017000200017 15.

  16. Panduro Barón J, Barrios Prieto E, Pérez Molina J, et al. Obesidad y sus complicaciones maternas y perinatales. Ginecol Obstet Mex [Internet]. 2021 [citado 12/03/2022];89(7):530-9. Disponible en: Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=100618 16.

  17. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 763: Ethical considerations for the care of patients with obesity. Obstet Gynecol [Internet]. 2019 [citado 12/03/2022];133(1):e90-396. Disponible en: Disponible en: https://doi.org/10.1097/aog.0000000000003015 17.

  18. National Institute for Heath and Care Excellence. Caesarean birth. NICE guideline (NG192) [Internet]. Londres: National Institute for Heath and Care Excellence; 31 mar 2021 [citado 12/03/2022]. Disponible en: Disponible en: https://www.nice.org.uk/guidance/ng192 18.

  19. Loor Cedeño L, Pincay Cardona L, Yumbo Santana YS, et al. Preeclampsia y complicaciones materno-fetales. Polo del Conocimiento. [Internet]. 2021 [citado 12/03/2022];6(2):101-9. Disponible en: Disponible en: https://polodelconocimiento.com/ojs/index.php/es/article/view/2239/html 19.

  20. Balestena J, Barrios M, Balestena A. Influencia de la hipertensión originada por el embarazo en el parto y el recién nacido. Rev Cien Méd Pinar Río [Internet]. 2014 [citado 12/03/2022];18(1):24-32. Disponible en: Disponible en: http://revcmpinar.sld.cu/index.php/publicaciones/article/view/1376 20.




2020     |     www.medigraphic.com